Key Drivers
- High Cash Conversion
- Strong Liquidity Position
- Premium Multiples
AIAI Summary
ResMed is evolving into a recurring-revenue sleep-health platform, with consumables, resupply, and digital adherence driving the strongest earnings durability; investors should favor the pullback only if margins hold amid cost inflation and Philips' return does not erode share or pricing.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High Cash Conversion
- •Strong Liquidity Position
- •Premium Multiples
RMD's exceptional margins, cash generation, liquidity, and capital returns support a high-quality profile, but its premium valuation and sizable intangibles warrant disciplined entry pricing.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support holding
- •Weak momentum
RMD remains technically cautious after last month's decline, with $218.27 support and upside confirmation requiring a reclaim of $228–$230.
Volatile rebound to $229.44 was followed by a retreat to $224.99
Sentiment & News
Key News Insights:
- •Strong EPS Growth
- •Market Share Upside
- •Legal Risk
ResMed's strong earnings, innovation, and institutional support underpin a constructive outlook, though competition and investor investigations remain key risks.
Overall news flow is positive for ResMed, supporting upside potential while legal and competitive risks warrant monitoring
Similar Companies in Healthcare
Other companies in the same sector with AI ratings